Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients (IMAGE)

Huntsman Cancer Institute

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Caption

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

Credit

Huntsman Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.